BIOMAT Database Logo BIOMAT Database Logo

Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis. 1998

T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
Department of Oral and Maxillofacial Surgery II, Hiroshima University School of Dentistry, Japan.

In the present study, we examined the expression of CD44 variant exons in human oral squamous cell carcinoma (OSCC). Of ten cell lines from OSCCs, two (KB and H357), as well as the HeLa cell line, failed to express CD44 variant exons. In surgical specimens, all normal mucosa expressed CD44v9 (both mRNA and protein). Of 40 primary OSCCs, 19 (47.5%) showed downregulation of CD44v9, which correlated with tumor cell differentiation, primary metastasis to lymph nodes and secondary metastasis to lymph nodes. The results suggest that the downregulation of CD44v9 may play a role in lymphatic metastasis of OSCC and changes in its expression may be a useful diagnostic tool to determine the metastatic potential of OSCC to lymph nodes. Moreover, three cell lines that failed to express CD44 variant exons might become a useful experimental model to study the role of variant exons in the progression of OSCC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
March 1995, Japanese journal of cancer research : Gann,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
August 1997, International journal of oral and maxillofacial surgery,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
Expression of CD44 variant exons by primary and metastatic oral squamous carcinomas.
August 1998, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
[Expression of CD44 variant 6 and its metastatic potential in squamous cell carcinoma of the oral cavity].
July 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
October 2002, International journal of oncology,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue.
November 2000, Oral oncology,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
Expression of CD44 variant exons by normal oral epithelia.
July 1997, Oral oncology,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
[Expression of variant CD44 in colorectal cancer and its relationship to liver metastasis].
July 1998, Nihon Geka Gakkai zasshi,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
January 2007, Oral oncology,
T Ue, and H Yokozaki, and K Kagai, and K Higashikawa, and W Yasui, and M Sugiyama, and E Tahara, and T Ishikawa
ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma.
February 2007, Virchows Archiv : an international journal of pathology,
Copied contents to your clipboard!